Vienna — The investigational monoclonal antibody trevogrumab was associated with lean mass preservation and greater loss of fat mass in people taking semaglutide, an interim trial data showed.

Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly due to underlying medical conditions. Other factors can contribute, like ...

As you age, you gradually lose muscle mass and gain visceral body fat, a type of fat deep inside your body that surrounds your heart, kidneys and other organs. Now, scientists say the ratio of ...

GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...

Fat, not skeletal muscle, accounted for most of the weight loss. According to the study, GLP-1 medicines reduced body fat in obese mice much more than lean body mass, and fat and liver mass fell ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Some patient populations may be at higher risk for lean ...

Semaglutide is commonly prescribed to support weight management and blood glucose control. While many individuals experience meaningful fat loss during treatment, some may also lose lean body mass.

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? There are two drugs, currently in clinical trials, aiming to help patients ...